ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2021. The put-call ratio across all filers is 8.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,565,108 | +31.6% | 156,104 | +70.3% | 0.45% | +18.9% |
| Q2 2023 | $4,229,567 | +204.9% | 91,688 | +165.1% | 0.38% | +145.8% |
| Q1 2023 | $1,387,099 | -19.0% | 34,591 | -6.4% | 0.15% | -20.7% |
| Q4 2022 | $1,712,496 | +3.1% | 36,963 | -7.9% | 0.19% | +18.4% |
| Q3 2022 | $1,661,000 | -68.3% | 40,114 | -51.2% | 0.16% | -67.0% |
| Q2 2022 | $5,245,000 | -17.8% | 82,206 | -6.4% | 0.49% | +5.6% |
| Q1 2022 | $6,379,000 | -36.8% | 87,837 | -26.8% | 0.47% | -27.4% |
| Q4 2021 | $10,090,000 | -16.7% | 119,993 | -10.7% | 0.64% | -18.0% |
| Q3 2021 | $12,118,000 | -25.7% | 134,357 | -21.4% | 0.79% | -26.9% |
| Q2 2021 | $16,304,000 | -6.0% | 170,996 | +12.3% | 1.08% | -13.8% |
| Q1 2021 | $17,344,000 | +126.4% | 152,326 | +175.3% | 1.25% | +118.5% |
| Q4 2020 | $7,660,000 | +97.1% | 55,336 | +22.0% | 0.57% | +65.8% |
| Q3 2020 | $3,887,000 | +17.3% | 45,346 | +7.1% | 0.34% | +3.9% |
| Q2 2020 | $3,313,000 | +159.2% | 42,349 | +47.2% | 0.33% | +100.0% |
| Q1 2020 | $1,278,000 | – | 28,765 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |